L B Heifets

1.1k total citations
11 papers, 841 citations indexed

About

L B Heifets is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, L B Heifets has authored 11 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 8 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in L B Heifets's work include Tuberculosis Research and Epidemiology (10 papers), Mycobacterium research and diagnosis (8 papers) and Cancer therapeutics and mechanisms (3 papers). L B Heifets is often cited by papers focused on Tuberculosis Research and Epidemiology (10 papers), Mycobacterium research and diagnosis (8 papers) and Cancer therapeutics and mechanisms (3 papers). L B Heifets collaborates with scholars based in United States. L B Heifets's co-authors include Pamela J. Lindholm-Levy, Salman H. Siddiqi, Angelo Scorpio, Michael H. Cynamon, Robert H. Gilman, Ying Zhang, Norman Goodman, Glenn D. Roberts, J. Kenneth McClatchy and Michael R Mcginnis and has published in prestigious journals such as Journal of Clinical Microbiology, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

L B Heifets

11 papers receiving 785 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L B Heifets United States 9 691 669 192 164 96 11 841
Pamela J. Lindholm-Levy United States 20 1.1k 1.5× 1.0k 1.5× 405 2.1× 205 1.3× 199 2.1× 23 1.3k
Suzanne E. Glickman United States 8 656 0.9× 403 0.6× 242 1.3× 130 0.8× 148 1.5× 12 899
Gertrud Meißner Germany 10 647 0.9× 682 1.0× 96 0.5× 242 1.5× 55 0.6× 72 853
Si-Yang Li United States 18 979 1.4× 819 1.2× 416 2.2× 228 1.4× 79 0.8× 27 1.2k
N Rist France 11 891 1.3× 798 1.2× 127 0.7× 369 2.3× 50 0.5× 42 1.0k
Kristian Ängeby Sweden 17 847 1.2× 781 1.2× 161 0.8× 229 1.4× 21 0.2× 30 972
Aurélie Chauffour France 18 895 1.3× 804 1.2× 335 1.7× 293 1.8× 78 0.8× 35 1.1k
Michelle S DeStefano United States 12 358 0.5× 293 0.4× 151 0.8× 111 0.7× 56 0.6× 20 532
M. Ruiz Spain 10 358 0.5× 308 0.5× 111 0.6× 114 0.7× 29 0.3× 23 544
A Devallois Guadeloupe 12 430 0.6× 513 0.8× 94 0.5× 157 1.0× 27 0.3× 15 607

Countries citing papers authored by L B Heifets

Since Specialization
Citations

This map shows the geographic impact of L B Heifets's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L B Heifets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L B Heifets more than expected).

Fields of papers citing papers by L B Heifets

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L B Heifets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L B Heifets. The network helps show where L B Heifets may publish in the future.

Co-authorship network of co-authors of L B Heifets

This figure shows the co-authorship network connecting the top 25 collaborators of L B Heifets. A scholar is included among the top collaborators of L B Heifets based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L B Heifets. L B Heifets is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Scorpio, Angelo, Pamela J. Lindholm-Levy, L B Heifets, et al.. (1997). Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 41(3). 540–543. 249 indexed citations
2.
Limbers, Christine A., et al.. (1997). 32nd US-Japan Conference on Tuberculosis and Leprosy, Cleveland, Ohio, USA, July 1997. Tubercle and Lung Disease. 78(3-4). 205–205. 1 indexed citations
3.
Meier, A, L B Heifets, Richard J. Wallace, et al.. (1996). Molecular Mechanisms of Clarithromycin Resistance in Mycobacterium avium: Observation of Multiple 238 rDNA Mutations in a Clonal Population. The Journal of Infectious Diseases. 174(2). 354–360. 83 indexed citations
4.
Heifets, L B, et al.. (1989). Does pyrazinoic acid as an active moiety of pyrazinamide have specific activity against Mycobacterium tuberculosis?. Antimicrobial Agents and Chemotherapy. 33(8). 1252–1254. 59 indexed citations
5.
Heifets, L B, et al.. (1988). Application of rapid methods (BACTEC system) in clinical mycobacteriology and in the search for new drugs.. PubMed. 63(2). 19–19. 1 indexed citations
6.
Heifets, L B, et al.. (1987). Determination of MICs of conventional and experimental drugs in liquid medium by the radiometric method against Mycobacterium avium complex.. PubMed. 13(9). 529–38. 26 indexed citations
7.
Heifets, L B, et al.. (1985). Radiometric method for testing susceptibility of mycobacteria to pyrazinamide in 7H12 broth. Journal of Clinical Microbiology. 21(2). 200–204. 22 indexed citations
8.
Heifets, L B, et al.. (1985). Determination of in vitro susceptibility of mycobacteria to ansamycin.. PubMed. 132(3). 710–1. 46 indexed citations
9.
Heifets, L B, et al.. (1985). Determination of in vitro susceptibility of Mycobacterium tuberculosis to cephalosporins by radiometric and conventional methods. Antimicrobial Agents and Chemotherapy. 27(1). 11–15. 53 indexed citations
10.
Roberts, Glenn D., Norman Goodman, L B Heifets, et al.. (1983). Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens. Journal of Clinical Microbiology. 18(3). 689–696. 245 indexed citations
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pamela J. Lindholm-Levy Breakdown of academic impact, for papers by Suzanne E. Glickman Breakdown of academic impact, for papers by Gertrud Meißner Breakdown of academic impact, for papers by Si-Yang Li Breakdown of academic impact, for papers by N Rist Breakdown of academic impact, for papers by Kristian Ängeby Breakdown of academic impact, for papers by Aurélie Chauffour Breakdown of academic impact, for papers by Michelle S DeStefano Breakdown of academic impact, for papers by M. Ruiz Breakdown of academic impact, for papers by A Devallois
Rankless by CCL
2026